by Editor | May 18, 2025 | Heart Disease Therapy, Procyon-Technologies News
Procyon Technologies was pleased to see the efficacy and viability of the iPSC-derived MSCs over 12 weeks while encapsulated in our proprietary immunoisolation devices. For more information, see https://www.biorxiv.org/search/10.1101%252F2025.04.01.646502. Cynata has...
by Editor | Jan 24, 2023 | Heart Disease Therapy, Procyon-Technologies News
A two-year grant from the Medical Research Future Fund’s Cardiovascular Health Mission will support a team led by St. Vincent’s Institute for Medical Research to develop a stem cell-based therapy for heart repair. For more information, see ...
by Editor | Mar 10, 2022 | Diabetes Therapy, Procyon-Technologies News
Procyon Technologies and Klearchos Papas are mentioned in a Nature Biotechnology article published in Feb 2022
by Editor | Dec 16, 2021 | Diabetes Therapy, Procyon-Technologies News
After hunting for decades, Drs. Klearchos Papas, Robert Johnson and Tom Loudovaris helped develop a bio-artificial pancreas at the University of Arizona Health Sciences. The team’s solution is composed of islet cells protected in a special oxygen-enabled pouch...
by Editor | May 6, 2021 | Diabetes Therapy, Procyon-Technologies News
At the invitation and request of the U.S. Food & Drug Administration (FDA), Klearchos Papas, Ph.D., presented on “Assessment of Islet Quality Pre-Transplant” at the advisory committee meeting of the Center for Biologics Evaluation and Research (CBER),...
